Transforming Stroke Care Through Advancements in Technology and an Overview of the PROSPR-SEA Post-Market Surveillance Study
Volume 5 Issue 2, pages 46-54
Received – 6th December 2019, Accepted – 9th December 2019
Italo Linfante Md, Faha
Medical Director of Interventional Neuroradiology and Endovascular Neurosurgery, Miami Clinic and Vascular Institute, 8900 North Kendall Drive, Miami, Florida, FL 33176.
Prof. Dr. Pham Minh Thong
Deputy Director in charge of Expertise, Bach Mai Hospital, 78 Gial Phong, Phuong Mai, Dong Da, Hanoi, Vietman.
Corresponding Author: Allison Kirsop – email@example.com
We thank Dr Allison Kirsop and Oruen Ltd. for medical writing and editorial assistance in the preparation of this manuscript.
Stroke is the second leading cause of disability and death worldwide, and many new techniques and tools are now available which improve clinical outcomes of stroke patients. New technologies currently being developed and used in surgical procedures are discussed in this meeting summary, along with an overview of a post-market registry study of stroke patients treated with Medtronic neuro-thrombectomy devices. The results of the important study known as PROSPR-SEA will provide essential real world data of stroke patient treatment outcomes in South East Asia.
Key words: Atrial Fibrillation; Cardiovascular Disease, Chronic Kidney Disease, Diabetes, Ischaemic Heart Disease; Stroke.